BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11120955)

  • 21. Phenotypic and genotypic characterization of antimicrobial resistance in Escherichia coli O111 isolates.
    Guerra B; Junker E; Schroeter A; Helmuth R; Guth BE; Beutin L
    J Antimicrob Chemother; 2006 Jun; 57(6):1210-4. PubMed ID: 16603644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutropenic Rat Thigh Infection Model for Evaluation of the Pharmacokinetics/Pharmacodynamics of Anti-Infectives.
    Yedle R; Reniguntla MK; Puttaswamy R; Puttarangappa P; Hiremath S; Nanjundappa M; Jayaraman R
    Microbiol Spectr; 2023 Aug; 11(4):e0013323. PubMed ID: 37260385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals.
    Zhao M; Yang M; Baranov E; Wang X; Penman S; Moossa AR; Hoffman RM
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9814-8. PubMed ID: 11481427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatiotemporal progression of localized bacterial peritonitis before and after open abdomen lavage monitored by in vivo bioluminescent imaging.
    Sharma PK; Engels E; Van Oeveren W; Ploeg RJ; van Henny der Mei C; Busscher HJ; Van Dam GM; Rakhorst G
    Surgery; 2010 Jan; 147(1):89-97. PubMed ID: 19733882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
    Lee YS; Han CH; Kang SH; Lee SJ; Kim SW; Shin OR; Sim YC; Lee SJ; Cho YH
    Int J Urol; 2005 Apr; 12(4):383-9. PubMed ID: 15948727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.
    Szabo D; Ostorhazi E; Binas A; Rozgonyi F; Kocsis B; Cassone M; Wade JD; Nolte O; Otvos L
    Int J Antimicrob Agents; 2010 Apr; 35(4):357-61. PubMed ID: 20031377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and genotypic antimicrobial resistance patterns of Escherichia coli isolated from dairy cows with mastitis.
    Srinivasan V; Gillespie BE; Lewis MJ; Nguyen LT; Headrick SI; Schukken YH; Oliver SP
    Vet Microbiol; 2007 Oct; 124(3-4):319-28. PubMed ID: 17544234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a bioluminescent Pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production.
    Thorn RM; Nelson SM; Greenman J
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3217-24. PubMed ID: 17638701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escherichia coli K-12 (pEGFPluxABCDEamp): a tool for analysis of bacterial killing by antibacterial agents and human complement activities on a real-time basis.
    Atosuo J; Lehtinen J; Vojtek L; Lilius EM
    Luminescence; 2013; 28(5):771-9. PubMed ID: 23129448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.
    Kunst MW; Mattie H; van Furth R
    Infection; 1979; 7(1):30-4. PubMed ID: 370021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of multi-resistant Escherichia coli.
    Guyot A; Barrett SP; Threlfall EJ; Hampton MD; Cheasty T
    J Hosp Infect; 1999 Sep; 43(1):39-48. PubMed ID: 10462638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the similarity of antimicrobial resistance phenotypes among fecal Escherichia coli isolates from two aggregated occupational cohorts of humans versus swine using cluster analysis and multivariate statistics.
    Alali WQ; Scott HM; Norby B
    Prev Vet Med; 2010 Apr; 94(1-2):77-83. PubMed ID: 20022646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
    Wong-Beringer A; Hindler J; Loeloff M; Queenan AM; Lee N; Pegues DA; Quinn JP; Bush K
    Clin Infect Dis; 2002 Jan; 34(2):135-46. PubMed ID: 11740699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Bae IK; Lee YN; Hwang HY; Jeong SH; Lee SJ; Kwak HS; Song W; Kim HJ; Youn H
    J Antimicrob Chemother; 2006 Dec; 58(6):1257-9. PubMed ID: 17003059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin.
    Salisbury V; Pfoestl A; Wiesinger-Mayr H; Lewis R; Bowker KE; MacGowan AP
    J Antimicrob Chemother; 1999 Jun; 43(6):829-32. PubMed ID: 10404323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.
    Zuluaga AF; Rodriguez CA; Agudelo M; Vesga O
    BMC Res Notes; 2015 Oct; 8():546. PubMed ID: 26445936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model.
    Haugan MS; Løbner-Olesen A; Frimodt-Møller N
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.